Watchlist Price Alert

Universe Pharmaceuticals ... (UPC)

NASDAQ: UPC · Real-Time Price · USD

3.92

-0.03 (-0.76%)

At close: Jun 17, 2025, 3:59 PM

3.80

-3.06%

After-hours: Jun 17, 2025, 07:06 PM EDT

Universe Pharmaceuticals INC Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q4 2018
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Sep 30, 2018
Cash & Equivalents	29.5M	8.86M	5.29M	12.95M	5.71M	14.24M	8.08M	36M	10.06M	11.8M	3.18M	6.19M
Short-Term Investments	n/a	2.53M	13.22M	13.31M	13.15M	14.34M	13.73M	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	712.49K	692.49K	685.31K	728.05K	702.89K	586.67K	744.92K	762.5K	735K	705.5K	700.5K	728K
Other Long-Term Assets	n/a	96.14K	n/a	2.33M	2.25M	2.52M	2.48M	n/a	n/a	n/a	n/a	n/a
Receivables	17.88M	14.38M	10.73M	17.52M	15.18M	19.17M	15.81M	17.8M	10.87M	4.39M	6.42M	7.64M
Inventory	1.74M	3.76M	3.34M	2.87M	2.21M	3.39M	2.46M	4.92M	1.91M	4.99M	2.62M	8.12M
Other Current Assets	852.42K	539.24K	626.24K	2.01M	1.72M	418.17K	174.05K	n/a	443.71K	90.93K	n/a	n/a
Total Current Assets	51.64M	33.53M	36.81M	52.52M	41.51M	51.66M	50.48M	61.81M	23.28M	21.29M	12.23M	21.96M
Property-Plant & Equipment	15.34M	14.96M	14.99M	13.8M	13.58M	15.43M	15.39M	4.4M	4.43M	4.45M	4.57M	5.08M
Goodwill & Intangibles	262.88K	147.65K	148.58K	160.47K	157.45K	178.76K	178.48K	178.57K	174.78K	170.3K	171.61K	183.58K
Total Long-Term Assets	16.32M	15.9M	16.48M	17.85M	18.03M	19.71M	19.66M	5.47M	5.52M	5.48M	5.61M	6.12M
Total Assets	67.95M	49.43M	53.29M	70.37M	59.54M	71.37M	70.14M	67.27M	28.8M	26.78M	17.84M	28.08M
Account Payables	4.91M	7.76M	4.59M	11.24M	3.08M	3.65M	5.31M	8.59M	2.69M	5.11M	1.94M	2.94M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	1.1M	1.44M	1.33M	694.44K	551.05K	893.51K
Short-Term Debt	5.86M	4.43M	5.48M	4.08M	3.94M	4.41M	4.33M	2.75M	2.65M	2.54M	2.52M	2.62M
Other Current Liabilities	n/a	8.24M	n/a	5.44M	3.38M	n/a	n/a	3.12M	n/a	n/a	n/a	11.7M
Total Current Liabilities	20.31M	20.61M	13.75M	23.24M	13.1M	10.21M	11.21M	16.58M	8M	9.3M	5.45M	18.4M
Long-Term Debt	2.14M	2.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	2.14M	2.08M	n/a	n/a	7.01M	8.06M	n/a	n/a	n/a	n/a	n/a	n/a
Total Liabilities	22.45M	22.69M	13.75M	23.24M	13.1M	10.21M	11.21M	16.58M	8M	9.3M	5.45M	18.4M
Total Debt	7.99M	6.51M	5.48M	4.08M	3.94M	4.41M	4.33M	2.75M	2.65M	2.54M	2.52M	2.62M
Common Stock	482.4K	68.36K	67.97K	67.97K	67.97K	67.97K	67.97K	67.97K	50K	50K	50K	50K
Retained Earnings	-10.17M	-2.94M	10.16M	15.61M	16.32M	26.79M	25.06M	20.89M	13.74M	11.25M	6.18M	2.83M
Comprehensive Income	1.33M	339.12K	26.27K	2.17M	772.83K	5.02M	4.53M	4.13M	3.33M	2.49M	2.47M	3.12M
Shareholders Equity	45.5M	26.74M	39.53M	47.13M	46.44M	61.16M	58.93M	50.69M	20.8M	17.48M	12.38M	9.68M
Total Investments	712.49K	3.22M	13.9M	14.04M	13.85M	14.93M	14.47M	762.5K	735K	705.5K	700.5K	728K